Morgan Sheng Appointed VP Neuroscience Research at Genentech

Article

Genentech, Inc. (South San Francisco, CA) has appointed Morgan Sheng, MD, PhD, vice president, neuroscience.

Genentech, Inc. (South San Francisco, CA) has appointed Morgan Sheng, MD, PhD, vice president, neuroscience. In this newly created position, Sheng will be responsible for directing neurobiology drug discovery efforts at Genentech and will oversee the department of neurobiology. Sheng will be joining Genentech from the Massachusetts Institute of Technology (MIT) where he is Menicon Professor of Neuroscience at the Picower Institute for Learning and Memory and RIKEN-MIT Neuroscience Research Center in the Departments of Brain and Cognitive Science, and Biology.

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content
© 2025 MJH Life Sciences

All rights reserved.